GTHP — GUIDED THERAPEUTICS INC

OTC · Health Care · Health Care Equipment & Supplies · CIK 924515 ·
Last close
$0.30
Market Cap
$28.96M
52W High
$0.34
52W Low
$0.18
ADV30
8,902
Next earnings
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 0 -302,000 -500,000 1,604,000 369,000 6,780,000
Dec 2025 590,000 458,000 -710,000 -1,218,000 1,324,000 63,000 7,330,000
Sep 2025 60,000 35,000 -485,000 -742,000 903,000 87,000 6,549,000
Jun 2025 117,000 79,000 -763,000 -811,000 940,000 185,000 6,412,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,354,000
Investing CF
$0
Financing CF
$1,610,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.04
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-158,068,000
Inventory
$469,000
Receivables
$4,000
ST Investments
EBIT TTM
$-2,650,000
Pretax Income TTM
$-3,271,000
Interest Exp TTM
$621,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$767,000
EBITDA
$-2,250,000
Free Cash Flow
$-880,625
Enterprise Value
$32,094,204
Total Cash
$369,000
Total Debt
$2,785,000
Shares Out
96,537,349
Trailing EPS
$-0.04
Book Value
$-0.06
ROE
ROA
-109.9%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 767,000 -2,372,000 -3,196,000 1,324,000 7,330,000 -1,068,000
Dec 2024 7,000 -2,108,000 -2,417,000 1,378,000 6,267,000 -1,119,000
Dec 2023 98,000 -3,457,000 -3,489,000 1,669,000 5,475,000 -1,746,000
Dec 2022 13,000 -3,333,000 -4,341,000 3,366,000 6,249,000 -1,479,000
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
RDGL VIVOS INC $28.35M $0.06
BEAT HeartBeam, Inc. $27.79M $0.50
NSPR InspireMD, Inc. $30.45M $0.65
PSTV PLUS THERAPEUTICS, INC. $26.64M $3.87
ARAY ACCURAY INC $32.02M $0.27

News headlines (Yahoo Finance, 1h cache)

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
2026-07-22 13:00 · Yahoo
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
2026-07-14 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.